financetom
Business
financetom
/
Business
/
Great Ajax to Become Rithm Capital's External Manager
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Great Ajax to Become Rithm Capital's External Manager
Jun 11, 2024 10:25 AM

01:00 PM EDT, 06/11/2024 (MT Newswires) -- Rithm Capital ( RITM ) and Great Ajax ( AJX ) said Tuesday they have completed their strategic transaction, with Great Ajax ( AJX ) entering into a management agreement with a Rithm Capital ( RITM ) affiliate to serve as its external manager.

The companies added that with the closing of the transaction, Rithm Capital ( RITM ) bought 2.9 million Great Ajax ( AJX ) common shares from Great Ajax ( AJX ) under a stock purchase agreement.

In connection with the completion of the transaction, Lawrence Mendelsohn resigned as chief executive of Great Ajax ( AJX ), the company said in a filing with the US Securities and Exchange Commission.

Great Ajax ( AJX ) said it appointed Michael Nierenberg to serve as its CEO.

Great Ajax ( AJX ) shares rose 4.1% and Rithm Capital ( RITM ) shares were down 1.3% in recent trading.

Price: 10.95, Change: -0.15, Percent Change: -1.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NV5 Global Names Ben Heraud CEO
NV5 Global Names Ben Heraud CEO
Jan 7, 2025
08:59 AM EST, 01/07/2025 (MT Newswires) -- NV5 Global ( NVEE ) said Tuesday it has named Ben Heraud the company's chief executive officer. Heraud has been the chief operating officer of NV5's buildings and technology group since 2020, the company said. NV5 also said that its Founder Dickerson Wright will continue indefinitely in his role as executive chair. The...
Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates
Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates
Jan 7, 2025
09:00 AM EST, 01/07/2025 (MT Newswires) -- Immuneering ( IMRX ) said Tuesday that new data from an ongoing phase 2a trial of its lead candidate IMM-1-104 in pancreatic cancer showed better overall response and disease control rates. The updated results for IMM-1-104 combined with modified gemcitabine/nab-paclitaxel showed pancreatic cancer patients achieved an overall response rate of 43% and a...
Innoviz Technologies Highlights Collaboration With Nvidia; Shares Advance
Innoviz Technologies Highlights Collaboration With Nvidia; Shares Advance
Jan 7, 2025
08:56 AM EST, 01/07/2025 (MT Newswires) -- Innoviz Technologies ( INVZ ) said Tuesday it has developed new autonomous driving sensor technologies running on Nvidia's ( NVDA ) DRIVE AGX Orin platform. The company said its collaboration with Nvidia ( NVDA ) allows for real-time processing and understanding of a vehicle's environment for object detection, classification and tracking. Innoviz (...
What's Going On With Hyperscale Stock Today?
What's Going On With Hyperscale Stock Today?
Jan 7, 2025
Hyperscale Data, Inc. ( GPUS/PD ) experienced a rise in its shares during the premarket session on Tuesday following the announcement that Ault & Company, Inc. has increased its controlling stake in Hyperscale Data ( GPUS/PD ). As of January 3, Ault & Company owns 91.7% of Hyperscale Data’s Class A common stock, totaling 13,900,765 shares. This includes shares acquired through the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved